Clinical Trial Update: Paxil CR Bioequivalence Study Brazil - Fed Administration [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of Paxil CR (paroxetine controlled-release) in Brazil for depressive disorder completed; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Paxil CR (paroxetine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder | Phase 1 | Status: COMPLETED | Results posted: 2011-04-20